High-Grade Neuroendocrine Carcinoma of the Head and Neck: Human Papillomavirus Status and PD-L1 Expression

Bahr, Katharina and Zimmer, Stefanie and Springer, Erik and Fottner, Christian and Becker, Sven and Ernst, Benjamin P. and Matthias, Christoph and Kuenzel, Julian (2019) High-Grade Neuroendocrine Carcinoma of the Head and Neck: Human Papillomavirus Status and PD-L1 Expression. ORL-JOURNAL FOR OTO-RHINO-LARYNGOLOGY HEAD AND NECK SURGERY, 81 (5-6). pp. 309-316. ISSN 0301-1569, 1423-0275

Full text not available from this repository. (Request a copy)

Abstract

Background: Human papillomavirus (HPV)-related head and neck squamous cell carcinoma represents an important subgroup of head and neck cancer, but HPV occurs also in the less common neuroendocrine carcinomas (NEC). The PD-1/PD-L1 pathway appears to be activated in pulmonary NEC and correlates with a higher mutation burden, but the potential of NEC to respond to checkpoint inhibitors is unknown to a large extent. Objectives: To determine the HPV status of NEC of the head and neck region and to investigate the expression of PD-1 and its ligands PD-L1 and PD-L2. Methods: Surgical tumor samples from 2006 to 2017 were analyzed. HPV status was determined by p16 immunohistochemistry (IHC) and multiplex PCR. IHC using the Cologne Score was performed for PD-1, PD-L1, and PD-L2. Results: Seven NEC tumor samples were analyzed, three of them showed HPV type 18. Expression of PD-1 and PD-L1 differed widely and showed no correlation to HPV status. IHC showed an overexpression of PD-L2 in most of the patients.

Item Type: Article
Uncontrolled Keywords: CELL LUNG-CANCER; PREDICTIVE BIOMARKER; PROGNOSTIC-FACTORS; OPEN-LABEL; OROPHARYNX; IMMUNOTHERAPY; PEMBROLIZUMAB; MULTICENTER; NIVOLUMAB; DISTINCT; Neuroendocrine carcinoma; Human papillomavirus; PD-L1; Head and neck; Immunotherapy
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Hals-Nasen-Ohren-Heilkunde
Depositing User: Dr. Gernot Deinzer
Date Deposited: 25 Mar 2020 09:34
Last Modified: 06 Apr 2020 06:17
URI: https://pred.uni-regensburg.de/id/eprint/25880

Actions (login required)

View Item View Item